UniPharma Balance Sheet Health
Financial Health criteria checks 6/6
UniPharma has a total shareholder equity of NT$306.3M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$336.5M and NT$30.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$137.73m |
| Equity | NT$306.34m |
| Total liabilities | NT$30.17m |
| Total assets | NT$336.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6621's short term assets (NT$190.5M) exceed its short term liabilities (NT$17.2M).
Long Term Liabilities: 6621's short term assets (NT$190.5M) exceed its long term liabilities (NT$12.9M).
Debt to Equity History and Analysis
Debt Level: 6621 is debt free.
Reducing Debt: 6621 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6621 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6621 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 27% each year